|
Listeria Monocytogenes Testing - Specimen Collection
August 29, 2008: Gamma-Dynacare is requesting the assistance of clinicians in helping to ensure that patients showing symptoms of listeriosis are appropriately tested.
|
|
Gamma-Dynacare Offers the Only FDA-Approved HPV Screening Test
December 1, 2007: Gamma-Dynacare Medical Laboratories offers an advanced technology and the ONLY FDA-approved adjunctive screening test available.
|
|
Gamma-Dynacare Expands Its Trace Metals Testing
December 1, 2007: Gamma-Dynacare Medical Laboratories has recently expanded its trace metal testing platform utilizing the latest technology used for trace metal detection, identification and quantification.
|
|
ColonCancerCheck: Improving Specimen Acceptability
July 4, 2008: Gamma-Dynacare is requesting the assistance of clinicians in helping to improve the rate of Fecal Occult Blood Test (FOBT) specimen acceptability.
|
|
Chlamydia Trachomatis - Upgraded Testing Methodology
July 4, 2008: Gamma-Dynacare has upgraded our Chlamydia trachomatis testing methodology to an advanced Gen-Probe Nucleic Acid Transcription Mediated Amplification (TMA) assay with superior sensitivity and specificity.
|
|
Serum Free Light Chain Analysis
September 10, 2008: With the recent addition of Freelite to our test menu, Gamma-Dynacare is pleased to ofer serum Free Light Chain (FLC) analysis as a further aid in the diagnosis and monitoring of monoclonal gammopathies.
|
|
Electronic Cytology Requisition Form
October 6, 2008: Gamma-Dynacare is pleased to introduce a new cytology requisition form that physicians and clients can download and complete electronically.
|
|
Electronic Histology Requisition Form
October 20, 2008: Gamma-Dynacare is pleased to introduce a new histology requisition form that physicians and clients can download and complete electronically.
|
|
Gamma-Dynacare Named One of Canada's Top 100 Employers
October 23, 2008: Gamma-Dynacare has been named one of Canada's Top 100 Employers for 2009 and one of the Greater Toronto Area's Top 75 Employers by Mediacorp Canada Inc.
|
|
Gamma-Dynacare To Acquire Central Medical Laboratories
November 28, 2008: Gamma-Dynacare has entered into a definitive agreement to acquire Central Medical Laboratories, Manitoba's largest provider of community laboratory services.
|
|
Swine Influenza Update
April 30, 2009: The Ontario Ministry of Health and Long-Term Care issued updated guidance today regarding laboratory testing for swine influenza A.
|
|
Manitoba A/H1N1 Influenza Update
May 6, 2009: Manitoba Health has developed a document that provides interim guidance for clinicians in ambulatory settings regarding laboratory testing for Novel A/H1N1 Influenza.
|
|
Requisitions for Ordering Supplies
June 9, 2009: Gamma-Dynacare provides supplies required by our regular clients for the collection of specimens.
|
|
Urine Specimen Container Recall
June 11, 2009: Gamma-Dynacare is requesting the assistance of clinicians in returning supplies of 90 ml urine specimen containers, as we are experiencing a leakage issue with a large number of these containers.
|
|
Ordering FOBT and Stool O/B Kits
June 15, 2009: Gamma-Dynacare is pleased to provide information to assist clinicians in ordering supplies of Fecal Occult Blood Test kits under the Ontario ColonCancerCheck screening program.
|
|
HPV DNA Testing
June 22, 2009: Human Papillomavirus (HPV) is now well established as the major etiologic agent for cervical cancer and its precursors. Studies demonstrate high-risk HPV types are found in more than 99.7% of cervical cancer cases.
|
|
Physician Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched by the Ontario Ministry of Health and Long-Term Care and Cancer Care Ontario.
|
|
Pharmacist Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched in Ontario by the Ministry of Health and Long-Term Care and Cancer Care Ontario.
|
|
PSA Insured Testing
January 9, 2009: The Ontario Ministry of Health and Long-Term Care is implementing a new policy to improve patient access through community laboratories to Prostate-Specific Antigen (PSA) testing.
|
|
Quebec A/H1N1 Influenza Update
May 6, 2009: The Quebec Public Health Laboratory has issued guidance regarding reporting and laboratory testing for A/H1N1 influenza.
|
|
Procedures for Referred CT/GC Testing
June 23, 2009: Gamma-Dynacare is currently validating the implementation of an upgraded testing methodology that offers testing for Chlamydia trachomatis (CT) as well as Neisseria gonorrhoeae (GC) on the same specimen.
|
|
Automated Cervical Cytology Screening
June 29, 2009: Gamma-Dynacare is pleased to introduce BD FocalPoint Slide Profiler Intelligent Pap Imaging systems into our Ontario cytology laboratories.
|
|
Routine Testing for Urogenital Syndromes
August 5, 2009: Beginning August 8, 2009, Gamma-Dynacare will test for Chlamydia trachomatis and Neisseria gonorrhoeae with one sample, either GenProbe Unisex swab or urine.
|
|
Shortage of Glucose Tolerance Test Beverage
September 23, 2009: Gamma-Dynacare wishes to inform clinicians of a current national shortage of the Trutol Glucose Tolerance Test Beverage, 50 grams and 75 grams.
|
|
Thyroglobulin
November 20, 2009: Due to issues relating to a change in reagent lot, Gamma-Dynacare has temporarily suspended in-house testing of thyroglobulin and is sending samples to a reference laboratory.
|
|
New OAML Guideline for Phoning of Critical Results
December 1, 2009: The Ontario Association of Medical Laboratories recently amended its Guideline for Reporting Laboratory Test Results.
|
|
Urine Preservative Tube Required for Microscopic Analysis
June 22, 2009: Effective July 1, 2009, all urine microscopic analyses must be submitted in a urine preservative tube.
|
|
MRSA and VRE: Inapprropriate Surveillance Sampling
December 2, 2009: The importance of methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) testing is now universally accepted with established collection and testing procedures.
|